The maker of OxyContin is seeking Food and Drug Administration approval to label the controversial painkiller for use by children as young as 6 in a move that could serve to extend the company’s expiring patent on the lucrative drug, The Daily has learned.
How sick.
http://www.thedaily.com/page/2012/07/02/070212-news-oxycontin-kids-1-4/
How sick.
http://www.thedaily.com/page/2012/07/02/070212-news-oxycontin-kids-1-4/